§ PHARMACEUTICALS
USD · PharmaceuticalsMAZE
MAZE THERAPEUTICS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
110 increased/new, 42 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.6M | 3.5% | ±0% |
| TRV GP IV, LLC | 4.5M | 50.0% | ±0% |
| ARCH Venture Management, LLC | 4.1M | 18.2% | ±0% |
| Deep Track Capital, LP | 3.5M | 1.7% | −18% |
| JANUS HENDERSON GROUP PLC | 2.9M | n/a | −9% |
| Paradigm Biocapital Advisors LP | 2.7M | 1.7% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for MAZE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER88.5% · 117 holders
QUALITY / COMPOUNDER14.9% · 11 holders
PASSIVE / INDEX7.3% · 8 holders
DEALER / BANK4.0% · 18 holders
TACTICAL / MACRO2.7% · 4 holders
SYSTEMATIC / QUANT0.7% · 5 holders
INCOME / DEFENSIVE0.5% · 5 holders
ACTIVIST0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for MAZE in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention MAZE yet.